Latest Internal Medicine News

Fellow Focus in Four: Jessica Zuo, MD, Clinician-Educator Fellow (Geriatrics)

An embedded electronic health record algorithm that provided HF mortality risk information did not affect clinical decision making about initiation or intensity of treatment or improve outcomes in adults with HF, data show.

Fellow Focus in Four: Leah Schecter, MD, Clinical Fellow (Geriatrics)

Late-Breaking Basic Science submissions for the AHA Scientific Sessions close August 23.

Breakthrough research in the study of forms of Gaucher disease that cause neurodegeneration has implications for individuals with rare diseases as well as those with common diseases.

Jonathan Hanna, MD, has been selected as a finalist for the American Heart Association’s Jay D. Coffman Early Career Investigator Award.

Some babies born with devastating birth defects from the mosquito-borne illness are 7 now, but Covid turned the world’s attention away.

A targeted therapy called Enhertu, which recently scored a major approval when it comes to treating advanced breast cancer, has now been given the green light by the Food and Drug Administration (FDA) to treat a certain type of lung cancer as well.

In joining the RISE registry, Yale Rheumatology will interface with a national organization.